[{"address1": "600/700, One Kendall Square", "address2": "Suite 7-201", "city": "Cambridge", "state": "MA", "zip": "02139", "country": "United States", "phone": "617 577 0300", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriasis . The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig R. Jalbert CIRA", "age": 63, "title": "President, Secretary, Principal Executive, Financial and Accounting Officer & Director", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chun  Zhang Ph.D.", "title": "Chief Technical Operations & Quality Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leslie  Wardwell-Scott Ph.D.", "title": "VP and Head of Corporate Development & Strategic Integration", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrea  Itano Ph.D.", "title": "Head of Research", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Duncan  McHale M.D., MBBS, Ph.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2017, "totalPay": 661968, "exercisedValue": 0, "unexercisedValue": 1128160}, {"maxAge": 1, "name": "Mr. Douglas  Maslin", "title": "Senior Director & Immunology Clinical Lead", "fiscalYear": 2017, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1514678400, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0001, "open": 0.0005, "dayLow": 0.0005, "dayHigh": 0.0005, "regularMarketPreviousClose": 0.0001, "regularMarketOpen": 0.0005, "regularMarketDayLow": 0.0005, "regularMarketDayHigh": 0.0005, "payoutRatio": 0.0, "beta": 0.523, "forwardPE": -5.4054053e-05, "volume": 133, "regularMarketVolume": 133, "averageVolume": 804, "averageVolume10days": 0, "averageDailyVolume10Day": 0, "bid": 0.0, "ask": 0.0, "bidSize": 29, "askSize": 10, "marketCap": 1898, "fiftyTwoWeekLow": 0.0001, "fiftyTwoWeekHigh": 0.0025, "allTimeHigh": 398.566, "allTimeLow": 0.0001, "fiftyDayAverage": 0.000296, "twoHundredDayAverage": 0.0004305, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 16687893, "profitMargins": 0.0, "floatShares": 18895938, "sharesOutstanding": 18982837, "sharesShort": 196993, "sharesShortPriorMonth": 156444, "sharesShortPreviousMonthDate": 1698710400, "dateShortInterest": 1701302400, "sharesPercentSharesOut": 0.0104, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 2.0000001e-05, "shortRatio": 0.12, "shortPercentOfFloat": 0.0222, "impliedSharesOutstanding": 18982837, "bookValue": -1.417, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -82349000, "trailingEps": -3.91, "forwardEps": -1.85, "lastSplitFactor": "1:20", "lastSplitDate": 1688083200, "enterpriseToEbitda": -0.24, "52WeekChange": -0.96, "SandP52WeekChange": 0.14684999, "quoteType": "EQUITY", "currentPrice": 0.0001, "recommendationKey": "none", "totalCash": 17262000, "totalCashPerShare": 0.912, "ebitda": -69674000, "totalDebt": 33948000, "quickRatio": 0.434, "currentRatio": 0.476, "returnOnAssets": -0.83247, "freeCashflow": -43313248, "operatingCashflow": -73701000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "EVLO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1525872600000, "regularMarketChange": 0.0, "regularMarketDayRange": "5.0E-4 - 5.0E-4", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 804, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "1.0E-4 - 0.0025", "fiftyTwoWeekHighChange": -0.0023999999, "fiftyTwoWeekHighChangePercent": -0.96, "fiftyTwoWeekChangePercent": -96.0, "earningsTimestampStart": 1751918400, "earningsTimestampEnd": 1752782400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.91, "epsForward": -1.85, "fiftyDayAverageChange": -0.00019600001, "fiftyDayAverageChangePercent": -0.6621622, "twoHundredDayAverageChange": -0.00033049998, "twoHundredDayAverageChangePercent": -0.76771194, "priceToBook": -7.057162e-05, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "shortName": "Evelo Biosciences, Inc.", "longName": "Evelo Biosciences, Inc.", "regularMarketTime": 1770325200, "exchange": "PNK", "messageBoardId": "finmb_331329033", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "cryptoTradeable": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0001, "displayName": "Evelo Biosciences", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]